Fedha

Hisa unazofuatilia
4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥ 1,903.00
+0.26%
(+5.00) Siku 1
5 Okt, 15:30:00 GMT +9  ·   JPY
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 4559...
Fungua
JP¥ 1,901
Juu
JP¥ 1,908
Chini
JP¥ 1,895
Mtaji wa soko
95.38B
Wastani wa kiasi cha mauzo
elfu 167.72
Kiasi cha mauzo ya hisa
elfu 125.40
Gawio
2.57%
Mgawo wa faida wa kila robo mwaka
JP¥ 12
Tarehe ya kutojumuisha gawio
29 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
10.19
Juu kwa wiki 52
JP¥ 2,434
Chini kwa wiki 52
JP¥ 1,878
EPS
JP¥ 187
Hisa za wawekezaji
50.11M
Idadi ya wafanyakazi
elfu 2
Fungua
JP¥ 1,901
Juu
JP¥ 1,908
Chini
JP¥ 1,895
Mtaji wa soko
95.38B
Wastani wa kiasi cha mauzo
elfu 167.72
Kiasi cha mauzo ya hisa
elfu 125.40
Gawio
2.57%
Mgawo wa faida wa kila robo mwaka
JP¥ 12
Tarehe ya kutojumuisha gawio
29 Sep 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
10.19
Juu kwa wiki 52
JP¥ 2,434
Chini kwa wiki 52
JP¥ 1,878
EPS
JP¥ 187
Hisa za wawekezaji
50.11M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Kuhusu Zeria Pharmaceutical Co Ltd
Afisa Mkuu Mtendaji (CEO)Sachiaki Ibe
Wafanyakazielfu 1.75
Lilianzishwa22 Des 1955
Makao makuu-
Sekta-
Ripoti za awaliThamani zote katika JPY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika JPY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
20.47B
24.12B
25.08B
21.45B
Gharama ya bidhaa zilizouzwa
5.59B
6.38B
6.43B
6.22B
Gharama ya mapato
5.59B
6.38B
6.43B
6.22B
Gharama za utafiti na maendeleo
-
-
3.71B
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
12.76B
12.82B
4.85B
13.28B
Gharama ya uendeshaji
12.76B
12.82B
14.84B
13.28B
Jumla ya gharama za uendeshaji
18.35B
19.19B
21.27B
19.50B
Mapato ya uendeshaji
2.12B
4.93B
3.81B
1.95B
Mapato mengine yasiyo ya uendeshaji
-23.00M
-81.04M
305.04M
-47.28M
EBT ikijumuisha vipengee visivyo vya kawaida
994.00M
4.63B
3.92B
1.43B
EBT bila kujumuisha vipengee visivyo vya kawaida
994.00M
4.63B
3.76B
1.43B
Gharama ya kodi ya mapato
383.00M
795.44M
979.56M
547.57M
Kiwango cha kodi kinachotumika
38.53%
-
25.02%
38.21%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
647.00M
3.82B
2.90B
866.20M
Kiwango cha faida halisi
3.16%
-
11.56%
4.04%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
30.00M
136.71M
32.29M
305.03M
Gharama ya riba
-119.00M
-123.00M
-138.00M
-132.04M
Jumla ya gharama halisi za riba
-89.00M
13.71M
-105.71M
172.99M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
5.78B
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
3.88B
6.81B
5.65B
4.24B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google